<DOC>
	<DOCNO>NCT00119743</DOCNO>
	<brief_summary>The purpose study ass efficacy young child prevent acute otitis medium due vaccine serotype pneumococcal non typable Hemophilus influenza , follow immunization 11-valent pneumococcal vaccine accord 3 dose primary vaccination first year life , booster dose second year life . Prophylactic immunization pneumococcal conjugate vaccine compare placebo ( hepatitis A vaccine ) .</brief_summary>
	<brief_title>A Efficacy Against Otitis Media Children With 11 Valent Pneumococcal Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male female 6 week 5 month ( 42152 day ) age time first vaccination . Use investigational nonregistered drug vaccine study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>27 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prophylaxis pneumococcal vaccine</keyword>
</DOC>